
Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Sam
(866) 682 9815

... Alfa was non-inferior to imiglucerase if the lower limit of the one-sided 97.5% Confidence interval (ci) of the treatment difference (velaglucerase alfa minus imiglucerase) was greater than -1 g ...
... E in upstream and downstream development. As an example of pharmaceutical proteins whole production processes of potential malaria vaccines are investigated in detail. In the field of technical enzymes ...
... monoclonal antibodies new products based on new science, these pose challenges in terms of industrialization and cost effectiveness tissue engineering cell therapies - autologous & allogeneic gene ...
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion Summary GBI Research, the leading business ...
Introduction The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a 20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing ...
INTRODUCTION STUDY GOALS AND OBJECTIVES This study provides a comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. Its aim is to provide a range of information, from detailed ...
Reportlinker.com © Copyright 2013. All rights reserved.